Search for Clinical Trial Results

Sponsored By

Primary Sclerosing Cholangitis - 12 Studies Found

Status Study
Completed Study Name: Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2011-04-25
Interventions:
  • Procedure: plastic endoprosthesis

Recruiting Study Name: Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Date: 2016-06-13
Interventions:
  • Drug: GS-9674 Tablet(s) admini
Completed Study Name: Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Date: 2012-08-22
Interventions:
  • Biological: Simtuzumab Other N
Active, not recruiting Study Name: Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Date: 2014-06-26
Interventions:
  • Drug: OCA
  • Drug: Placebo
Completed Study Name: Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis (PSC)
Date: 2014-02-11
Interventions: Drug: LUM001 LUM001 oral dose
Recruiting Study Name: Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Date: 2015-12-09
Interventions: Device: probe based confocal laser endomicroscopy real-time, microscopic imaging of tissue at the cellul
NOT_YET_RECRUITING Study Name: CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
Condition:
Date: 2024-10-13
Interventions: Oral QD
RECRUITING Study Name: Detoxification of the Liver In PSC (Dolphin)
Condition: Primary Sclerosing Cholangitis
Date: 2024-10-13
Interventions: Groups 1, 2, 3, and 4 will all contain 7 subjects each, with each subject receiving active study drug and placebo in a randomized order; half will rec
RECRUITING Study Name: Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Condition: Primary Sclerosing Cholangitis
Date: 2024-10-13
RECRUITING Study Name: Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Condition: Primary Sclerosing Cholangitis
Date: 2024-10-13
Interventions: Rosuvastatin 20 mg tablet once daily by mouth
Next >>>